Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kangbaida Biotechnology is a Chinese medical technology company that specializes in the development, production, and distribution of in vitro diagnostic (IVD) reagents. Founded in 2011 and headquartered in the Beijing Economic-Technological Development Area, the company focuses on biochemical diagnostic solutions, including kits for liver and kidney function, blood lipids, and cardiovascular disease markers. Kangbaida operates a GMP-certified manufacturing facility and provides a comprehensive portfolio of reagents compatible with major automated biochemical analyzers. The company serves a broad network of hospitals and clinical laboratories across China, positioning itself as a reliable provider of clinical chemistry reagents. Its business model emphasizes high-quality diagnostic tools to support accurate clinical decision-making and patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangbaida Biotechnology.